Works matching IS 08876924 AND DT 2010 AND VI 24 AND IP 1

Results: 41

Myelodysplastic syndromes: lost between two states?

Published in:

2010

By:

Acquaviva, C.;
Gelsi-Boyer, V.;
Birnbaum, D.

Publication type:

Editorial

Identification of a novel TEL–Lyn fusion gene in primary myelofibrosis.

Published in:

2010

By:

Tanaka, H.;
Takeuchi, M.;
Takeda, Y.;
Sakai, S.;
Abe, D.;
Ohwada, C.;
Sakaida, E.;
Shimizu, N.;
Saito, Y.;
Miyagi, S.;
Iwama, A.;
Nakaseko, C.

Publication type:

Letter

Analyses of TET2 mutations in post-myeloproliferative neoplasm acute myeloid leukemias.

Published in:

2010

By:

Couronné, L.;
Lippert, E.;
Andrieux, J.;
Kosmider, O.;
Radford-Weiss, I.;
Penther, D.;
Dastugue, N.;
Mugneret, F.;
Lafage, M.;
Gachard, N.;
Nadal, N.;
Bernard, O. A.;
Nguyen-Khac, F.;
Couronné, L

Publication type:

Letter

Characterizing chromosomal break points of t(12;21)[ETV6–RUNX1]-positive leukaemia using multiple tiling PCR on whole-genome-amplified DNA.

Published in:

2010

By:

Lausten-Thomsen, U.;
Madsen, H. O.;
Schmiegelow, K.

Publication type:

Letter

Extensive mutational status of genes and clinical outcome in pediatric acute myeloid leukemia.

Published in:

2010

By:

Lapillonne, H.;
Llopis, L.;
Auvrignon, A.;
Renneville, A.;
Labopin, M.;
Mazingue, F.;
Perot, C.;
Lai, J.-L.;
Philippe, N.;
Ballerini, P.;
Zurawski, V.;
Adam, M.;
Douay, L.;
Leverger, G.;
Landman-Parker, J.;
Preudhomme, C.

Publication type:

Letter

Identification of native, immunogenic peptides from Cyclin D1.

Published in:

2010

By:

von Bergwelt-Baildon, M. S.;
Shimabukuro-Vornhagen, A.;
Wendtner, C. M.;
Kondo, E.

Publication type:

Letter

A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence.

Published in:

Leukemia (08876924), 2010, v. 24, n. 1, p. 125, doi. 10.1038/leu.2009.186

By:

Darzentas, N.;
Hadzidimitriou, A.;
Murray, F.;
Hatzi, K.;
Josefsson, P.;
Laoutaris, N.;
Moreno, C.;
Anagnostopoulos, A.;
Jurlander, J.;
Tsaftaris, A.;
Chiorazzi, N.;
Belessi, C.;
Ghia, P.;
Rosenquist, R.;
Davi, F.;
Stamatopoulos, K.

Publication type:

Article

Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients.

Published in:

2010

By:

Gunnarsson, R.;
Isaksson, A.;
Mansouri, M.;
Göransson, H.;
Jansson, M.;
Cahill, N.;
Rasmussen, M.;
Staaf, J.;
Lundin, J.;
Norin, S.;
Buhl, A. M.;
Smedby, K. E.;
Hjalgrim, H.;
Karlsson, K.;
Jurlander, J.;
Juliusson, G.;
Rosenquist, R.

Publication type:

Letter

TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p.

Published in:

2010

By:

Jasek, M.;
Gondek, L. P.;
Bejanyan, N.;
Tiu, R.;
Huh, J.;
Theil, K. S.;
O'Keefe, C.;
McDevitt, M. A.;
Maciejewski, J. P.

Publication type:

Letter

Low or undetectable numbers of Philadelphia chromosome-positive leukemic stem cells (Ph+CD34+CD38neg) in chronic myeloid leukemia patients in complete cytogenetic remission after tyrosine kinase inhibitor therapy.

Published in:

2010

By:

Mustjoki, S.;
Rohon, P.;
Rapakko, K.;
Jalkanen, S.;
Koskenvesa, P.;
Lundán, T.;
Porkka, K.

Publication type:

Letter

Stem cell traits in long-term co-culture revealed by time-lapse imaging.

Published in:

2010

By:

Song, Y.;
Bahnson, A.;
Hall, N.;
Yu, H.;
Shen, H.;
Koebler, D.;
Houck, R.;
Xie, Y.;
Cheng, T.

Publication type:

journal article

Single-cell analysis reveals oligoclonality among 'low-count' monoclonal B-cell lymphocytosis.

Published in:

2010

By:

Lanasa, M. C.;
Allgood, S. D.;
Volkheimer, A. D.;
Gockerman, J. P.;
Whitesides, J. F.;
Goodman, B. K.;
Moore, J. O.;
Weinberg, J. B.;
Levesque, M. C.

Publication type:

journal article

Choosing the best treatment strategy for chronic myeloid leukemia patients resistant to imatinib: weighing the efficacy and safety of individual drugs with BCR-ABL mutations and patient history.

Published in:

2010

By:

Jabbour, E.;
Hochhaus, A.;
Cortes, J.;
La Rosée, P.;
Kantarjian, H. M.;
La Rosée, P

Publication type:

journal article

A phase I/II trial of TLR-7 agonist immunotherapy in chronic lymphocytic leukemia.

Published in:

2010

By:

Spaner, D. E.;
Shi, Y.;
White, D.;
Shaha, S.;
He, L.;
Masellis, A.;
Wong, K.;
Gorczynski, R.

Publication type:

Letter

The function of the pleckstrin homology domain in BCR–ABL-mediated leukemogenesis.

Published in:

2010

By:

Demehri, S.;
O'Hare, T.;
Eide, C. A.;
Smith, C. A.;
Tyner, J. W.;
Druker, B. J.;
Deininger, M. W. N.

Publication type:

Letter

Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR–ABL1-positive acute lymphoblastic leukemia patients.

Published in:

Leukemia (08876924), 2010, v. 24, n. 1, p. 66, doi. 10.1038/leu.2009.197

By:

Iacobucci, I.;
Lonetti, A.;
Messa, F.;
Ferrari, A.;
Cilloni, D.;
Soverini, S.;
Paoloni, F.;
Arruga, F.;
Ottaviani, E.;
Chiaretti, S.;
Messina, M.;
Vignetti, M.;
Papayannidis, C.;
Vitale, A.;
Pane, F.;
Piccaluga, P. P.;
Paolini, S.;
Berton, G.;
Baruzzi, A.;
Saglio, G.

Publication type:

Article

Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin's lymphoma cell lines.

Published in:

2010

By:

Wilcox, R. A.;
Sun, D. X.;
Novak, A.;
Dogan, A.;
Ansell, S. M.;
Feldman, A. L.

Publication type:

Letter

Analysis of factors that affect in vitro chemosensitivity of leukaemic stem and progenitor cells to gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukaemia.

Published in:

2010

By:

Jawad, M.;
Seedhouse, C.;
Mony, U.;
Grundy, M.;
Russell, N. H.;
Pallis, M.

Publication type:

journal article

PTPN11 mutations in childhood acute lymphoblastic leukemia occur as a secondary event associated with high hyperdiploidy.

Published in:

2010

By:

Molteni, C. G.;
te Kronnie, G.;
Bicciato, S.;
Villa, T.;
Tartaglia, M.;
Basso, G.;
Biondi, A.;
Cazzaniga, G.

Publication type:

Letter

EVI-1 interacts with histone methyltransferases SUV39H1 and G9a for transcriptional repression and bone marrow immortalization.

Published in:

Leukemia (08876924), 2010, v. 24, n. 1, p. 81, doi. 10.1038/leu.2009.202

By:

Goyama, S.;
Nitta, E.;
Yoshino, T.;
Kako, S.;
Watanabe-Okochi, N.;
Shimabe, M.;
Imai, Y.;
Takahashi, K.;
Kurokawa, M.

Publication type:

Article

DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4.

Published in:

Leukemia (08876924), 2010, v. 24, n. 1, p. 169, doi. 10.1038/leu.2009.203

By:

Bardini, M.;
Spinelli, R.;
Bungaro, S.;
Mangano, E.;
Corral, L.;
Cifola, I.;
Fazio, G.;
Giordan, M.;
Basso, G.;
De Rossi, G.;
Biondi, A.;
Battaglia, C.;
Cazzaniga, G.

Publication type:

Article

Successful treatment of molecular relapse in NPM1-positive AML using 5-azacytidine.

Published in:

2010

By:

Wermke, M.;
Thiede, C.;
Kiani, A.;
Ehninger, G.;
Bornhäuser, M.;
Platzbecker, U.

Publication type:

Letter

In vivo dynamics of human cord blood-derived CD34− SCID-repopulating cells using intra-bone marrow injection.

Published in:

Leukemia (08876924), 2010, v. 24, n. 1, p. 162, doi. 10.1038/leu.2009.206

By:

Kimura, T.;
Matsuoka, Y.;
Murakami, M.;
Takahashi, M.;
Nakamoto, T.;
Yasuda, K.;
Matsui, K.;
Kobayashi, K.;
Imai, S.;
Asano, H.;
Nakatsuka, R.;
Uemura, Y.;
Sasaki, Y.;
Sonoda, Y.

Publication type:

Article

Recruitment of PKC-βII to lipid rafts mediates apoptosis-resistance in chronic lymphocytic leukemia expressing ZAP-70.

Published in:

Leukemia (08876924), 2010, v. 24, n. 1, p. 141, doi. 10.1038/leu.2009.216

By:

Meyer zum Büschenfelde, C.;
Wagner, M.;
Lutzny, G.;
Oelsner, M.;
Feuerstacke, Y.;
Decker, T.;
Bogner, C.;
Peschel, C.;
Ringshausen, I.

Publication type:

Article

Oral fludarabine in untreated patients with B-cell chronic lymphocytic leukemia.

Published in:

2010

By:

Shustik, C.;
Turner, A. R.;
Desjardins, P.;
Fernandez, L.;
Rubin, S.;
Larratt, L.;
Duncan, A. M. V.;
Rizi, D.;
Sadura, A.;
Shepherd, L.;
Li, D.;
Rassenti, L.;
Kipps, T.

Publication type:

Letter

Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53.

Published in:

2010

By:

Gefen, N.;
Binder, V.;
Zaliova, M.;
Linka, Y.;
Morrow, M.;
Novosel, A.;
Edry, L.;
Hertzberg, L.;
Shomron, N.;
Williams, O.;
Trka, J.;
Borkhardt, A.;
Izraeli, S.

Publication type:

journal article

Selective FLT3 inhibitor FI-700 neutralizes Mcl-1 and enhances p53-mediated apoptosis in AML cells with activating mutations of FLT3 through Mcl-1/Noxa axis.

Published in:

2010

By:

Kojima, K.;
Konopleva, M.;
Tsao, T.;
Andreeff, M.;
Ishida, H.;
Shiotsu, Y.;
Jin, L.;
Tabe, Y.;
Nakakuma, H.

Publication type:

journal article

Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia.

Published in:

2010

By:

Jotta, P. Y.;
Ganazza, M. A.;
Silva, A.;
Viana, M. B.;
da Silva, M. J.;
Zambaldi, L. J. G.;
Barata, J. T.;
Brandalise, S. R.;
Yunes, J. A.

Publication type:

Letter

Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome.

Published in:

Leukemia (08876924), 2010, v. 24, n. 1, p. 242, doi. 10.1038/leu.2009.210

By:

Jongmans, M. C. J.;
Kuiper, R. P.;
Carmichael, C. L.;
Wilkins, E. J.;
Dors, N.;
Carmagnac, A.;
Schouten-van Meeteren, A. Y. N.;
Li, X.;
Stankovic, M.;
Kamping, E.;
Bengtsson, H.;
Schoenmakers, E. F. P. M.;
van Kessel, A. Geurts;
Hoogerbrugge, P. M.;
Hahn, C. N.;
Brons, P. P.;
Scott, H. S.;
Hoogerbrugge, N.

Publication type:

Article

Aberrant telomere structure is characteristic of resistant chronic lymphocytic leukaemia cells.

Published in:

2010

By:

Brugat, T.;
Gault, N.;
Baccelli, I.;
Maës, J.;
Roborel de Climens, A.;
Nguyen-Khac, F.;
Davi, F.;
Merle-Béral, H.;
Gilson, E.;
Goodhardt, M.;
Delic, J.

Publication type:

Letter

Involvement of RhoH GTPase in the development of B-cell chronic lymphocytic leukemia.

Published in:

2010

By:

Sanchez-Aguilera, A.;
Rattmann, I.;
Drew, D. Z.;
Müller, L. U. W.;
Summey, V.;
Lucas, D. M.;
Byrd, J. C.;
Croce, C. M.;
Gu, Y.;
Cancelas, J. A.;
Johnston, P.;
Moritz, T.;
Williams, D. A.;
Müller, L U W

Publication type:

journal article

A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cells.

Published in:

2010

By:

Rix, U.;
Rix, L. L. Remsing;
Terker, A. S.;
Fernbach, N. V.;
Hantschel, O.;
Planyavsky, M.;
Breitwieser, F. P.;
Herrmann, H.;
Colinge, J.;
Bennett, K. L.;
Augustin, M.;
Till, J. H.;
Heinrich, M. C.;
Valent, P.;
Superti^Furga, G.;
Remsing Rix, L L

Publication type:

journal article

TNF-alpha-converting enzyme (TACE/ADAM17)-dependent loss of CD30 induced by proteasome inhibition through reactive oxygen species.

Published in:

2010

By:

Vahdat, A. M.;
Reiners, K. S.;
Simhadri, V. L.;
Eichenauer, D. A.;
Böll, B.;
Chalaris, A.;
Simhadri, V. R.;
Wiegmann, K.;
Krell, H.-W.;
John, S. Rose;
Engert, A.;
von Strandmann, E. P.;
Hansen, H. P.;
Böll, B;
Rose-John, S

Publication type:

journal article

Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles.

Published in:

2010

By:

Shaw, B. E.;
Mayor, N. P.;
Russell, N. H.;
Apperley, J. F.;
Clark, R. E.;
Cornish, J.;
Darbyshire, P.;
Ethell, M. E.;
Goldman, J. M.;
Little, A.-M.;
Mackinnon, S.;
Marks, D. I.;
Pagliuca, A.;
Thomson, K.;
Marsh, S. G. E.;
Madrigal, J. A.

Publication type:

journal article

Targeted therapy in T-cell malignancies: dysregulation of the cellular signaling pathways.

Published in:

2010

By:

Zhao, W.-L.

Publication type:

journal article

WAVE1 regulates Bcl-2 localization and phosphorylation in leukemia cells.

Published in:

2010

By:

Kang, R.;
Tang, D.;
Yu, Y.;
Wang, Z.;
Hu, T.;
Wang, H.;
Cao, L.

Publication type:

journal article

JAK2 germline genetic variation affects disease susceptibility in primary myelofibrosis regardless of V617F mutational status: nullizygosity for the JAK2 46/1 haplotype is associated with inferior survival.

Published in:

Leukemia (08876924), 2010, v. 24, n. 1, p. 105, doi. 10.1038/leu.2009.225

By:

Tefferi, A.;
Lasho, T. L.;
Patnaik, M. M.;
Finke, C. M.;
Hussein, K.;
Hogan, W. J.;
Elliott, M. A.;
Litzow, M. R.;
Hanson, C. A.;
Pardanani, A.

Publication type:

Article

The JAK2 46/1 haplotype confers susceptibility to essential thrombocythemia regardless of JAK2V617F mutational status—clinical correlates in a study of 226 consecutive patients.

Published in:

Leukemia (08876924), 2010, v. 24, n. 1, p. 110, doi. 10.1038/leu.2009.226

By:

Pardanani, A.;
Lasho, T. L.;
Finke, C. M.;
Gangat, N.;
Wolanskyj, A. P.;
Hanson, C. A.;
Tefferi, A.

Publication type:

Article

Heat stress triggers apoptosis by impairing NF-kappaB survival signaling in malignant B cells.

Published in:

2010

By:

Belardo, G.;
Piva, R.;
Santoro, M. G.

Publication type:

journal article

Cathepsin B release after imatinib-mediated lysosomal membrane permeabilization triggers BCR–ABL cleavage and elimination of chronic myelogenous leukemia cells.

Published in:

Leukemia (08876924), 2010, v. 24, n. 1, p. 115, doi. 10.1038/leu.2009.233

By:

Puissant, A.;
Colosetti, P.;
Robert, G.;
Cassuto, J.-P.;
Raynaud, S.;
Auberger, P.

Publication type:

Article

Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma.

Published in:

2010

By:

Quach, H.;
Ritchie, D.;
Stewart, A. K.;
Neeson, P.;
Harrison, S.;
Smyth, M. J.;
Prince, H. M.

Publication type:

journal article